Globus Medical GMED Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's financing cash flow?
- Globus Medical (GMED) reported financing cash flow of $18.2M in Q1 2026.
- How has Globus Medical's financing cash flow changed year-over-year?
- Globus Medical's financing cash flow increased by 102.9% year-over-year, from -$635.4M to $18.2M.
- What is the long-term trend for Globus Medical's financing cash flow?
- Over 2 years (2021 to 2025), Globus Medical's financing cash flow has grown at a 254.3% compound annual growth rate (CAGR), from $55.17M to -$692.38M.
- What does financing cash flow mean?
- The net amount of cash a company receives from or pays to its investors and lenders.
- How do you interpret financing cash flow?
- An increase may signal capital raising or debt issuance, while a decrease often indicates debt reduction or significant share buybacks.
- How does financing cash flow compare across companies?
- Peers in the medical device sector typically show negative values during periods of debt deleveraging or aggressive capital return programs.